Medizinische Universität Graz - Research portal
Lichem Roland |
** = Publications listed in SCI/SSCI/Pubmed
2021
Full paper/article (Journal)
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Kölli, C; Gruber, B; Sator, PG; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Painsi, C; Selhofer, S; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Tanew, A; Inzinger, M; Tatarski, R; Bangert, C; Ellersdorfer, C; Lichem, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Schmiedberger, E; Strohal, R; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hoetzenecker, W; Trautinger, F; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Br J Dermatol. 2021; 184(6):1094-1105
Doi: 10.1111/bjd.19701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Weger, W; Sator, PG; Salmhofer, W; Gruber, B; Jonak, C; Kölli, C; Schütz-Bergmayr, M; Vujic, I; Ratzinger, G; Häring, N; Painsi, C; Prillinger, K; Mlynek, A; Skvara, H; Trattner, H; Tanew, A; Lichem, R; Ellersdorfer, C; Legat, F; Gruber-Wackernagel, A; Hofer, A; Schmiedberger, E; Hoetzenecker, W; Müllegger, R; Saxinger, W; Quehenberger, F; Wolf, P
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.
JAAD Int. 2021; 2: 62-75.
Doi: 10.1016/j.jdin.2020.10.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Full paper/article (Journal)
** Busard, CI; Cohen, AD; Wolf, P; Gkalpakiotis, S; Cazzaniga, S; Stern, RS; Hutten, BA; Feldhamer, I; Quehenberger, F; Lichem, R; Kojanova, M; Adenubiova, E; Addis, A; Naldi, L; Spuls, PI
Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
J Eur Acad Dermatol Venereol. 2018; 32(2):245-253
Doi: 10.1111/jdv.14583
Web of Science
PubMed
FullText
FullText_MUG
2017
Abstract (Journal)
** Wolf, P; Weger, W; Richter, L; Mlynek, A; Sator, P; Saxinger, W; Ratzinger, G; Kolli, C; Painsi, C; Bangert, C; Tatarski, R; Schutz-Bergmayr, M; Ponholzer, P; Trautinger, F; Strohal, R; Mullegger, R; Inzinger, M; Lichem, R; Salmhofer, W; Quehenberger, F
Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)
BRIT J DERMATOL. 2017; 177(5): E250-E250.
[Oral Communication]
Web of Science
2016
Case Report
** Koch, L; Lichem, R; Cerroni, L; Aberer, W; Massone, C
Dermatitis, nonmelanoma skin cancer and leg ulcers.
CLIN EXP DERMATOL. 2016; 41(8): 943-944.
Doi: 10.1111/ced.12896
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG